Evidence map›Paper›PMID 36224668›Full record

ArticleJournal of medical case reports2022

Macular telangiectasia with bilateral obliterated capillaries: a case report.

Melika Samadi, Afsaneh Azarkish, Hamid Riazi-Esfahani, Alireza Mahmoudi, Nazanin Ebrahimiadib

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Melika SamadiRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Afsaneh AzarkishDepartment of Ophthalmology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
Hamid Riazi-EsfahaniRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Alireza MahmoudiRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Nazanin EbrahimiadibRetina Service, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. nazanin.ebrahimiadib@gmail.com.ORCID http://orcid.org/0000-0002-2058-9225

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe report an otherwise healthy adult with macular telangiectasia with aneurysms, ischemia, and obliterated capillaries in both eyes.

methodsThis is a case report with a brief literature review. CASE PRESENTATION: A 58-year-old Iranian woman presented with a gradual decrease in vision, with recent deterioration. Past medical history was unremarkable, and best-corrected visual acuity was 3/10 in both eyes. Multimodal imaging including fundus photo, fluorescein angiography, optical coherence tomography, and optical coherence tomography angiography was carried out. In macula of both eyes, parafoveal telangiectasia, occluded vessels, capillary dropouts, and aneurysms were observed. While there were a dense circinate exudation and edema in the macula of the right eye and a thin and disorganized inner retinal layer in the left eye, the outer retina was intact in both eyes. En face optical coherence tomography angiography revealed capillary blunting and rarefaction in both superficial and deep capillary plexuses of retina.

conclusionOur case most probably represents a case of type 3 macular telangiectasia in the absence of any systemic association.

Indexed as

Diabetic RetinopathyTelangiectasisAdultCapillariesFemaleFluorescein AngiographyHumansIranMiddle AgedRetinal VesselsTomography, Optical CoherenceMacTel classificationMacTel type 3Macular telangiectasia

Identifiers

PMID36224668
PMCPMC9558415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.